New for 2020, ASGCT is changing the Pre-Meeting Workshop program to offer more half-day sessions. Official schedules to follow in the coming weeks. All Pre-Meeting Workshops will take place Monday, May 11, 2020. Each workshop has an individual registration rate, and attendees may register for any or all workshops independent of, or in addition to, registration for the Annual Meeting.
|U.S. Federal Government
|Nonmember Graduate Students
& Postdoctoral Fellows
Gene Editing: The Gene Editing workshop will provide an overview of current gene editing technologies and approaches, emerging uses and applications, with sessions highlighting junior investigators and clinical gene editing programs.
Commercialization I: The Commercialization workshop I will focus on the regulatory pathways to the commercialization of gene and cell therapy products with discussions covering the harmonization of global regulatory approaches.
Commercialization II: The Commercialization workshop II will focus on the unique challenges emerging technologies pose in designing acceptable business models to maximize patient access and discussions of value based pricing and reimbursement for gene therapies.
Viral Vector Development: The Viral Vector Development workshop will provide an in-depth discussion of the advances as well as the challenges in vector development and manufacturing, including GMP production.
Oncolytic Viruses: The Oncolytic Viruses workshop will feature overviews of the recent advances in oncolytics, including oncolytic viruses, cancer vaccines, and novel combination immuno-oncologic therapies.
CAR T and Immune Effector Cell Therapies: The CAR T and Related Immune Effector Cell Therapies Workshop will feature discussions of the current state of CAR T therapeutic approaches in light of recent FDA approvals with updates on clinical long term follow-up gene editing and going beyond autologous CAR-T cells for cancer.
Stem Cell Therapies: The Stem Cell Therapies workshop will feature a diverse offering of presentations covering a broad array of topics in stem cell therapies, including scientific advances and clinical applications.
Clinical Trials Training I: The Clinical Trials Training workshop I will address the development of early stage clinical trials, specifically covering the journey from preclinical development to clinical trial implementation and is intended primarily for early stage investigators.
Clinical Trials Training II: The Clinical Trials Training workshop II will provide an in-depth discussion, including case studies and first-hand accounts, of the development and launch of gene therapy clinical trials, both in academia and in commercial settings.
Abstract Submission Closes
January 31, 2020
Abstract Notifications Sent
April 6, 2020
Early Registration Ends
April 10, 2020
April 28, 2020
23rd ASGCT Annual Meeting
May 12 – 15, 2020
Use the ASGCT app on your mobile device to build your schedule, read the abstracts (released on April 28), and guide your way through the Hynes Convention Center.
Hynes Convention Center
900 Boylston St, Boston, MA 02115